SEC Tracker
Get the app

SANUWAVE Health SNWV

Sanuwave Health reported a $1.42 million net loss

SANUWAVE Health (SNWV) filed a 10-Q with the SEC on Nov 10, 2026, 4:46 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $8.58 million for the three months ended Sep 30, 2026
  2. Net loss: $1.42 million for the three months ended Sep 30, 2026
  3. Diluted EPS: -$0.16 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $6.57 million at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when SANUWAVE Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

1 new risk factor

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange vs prior 10-Q
Revenue$8.58M$9.74M−12%
Operating income and margin−$1.07M · -12.5%−$280K · -2.9%−283%, margin −9.6 pts
Net income−$1.42M−$682K−108%
Operating cash flow−$851K$425K−300%
Cash$6.57M$9.38M−30%
New risk factors (1)
  • Except as set forth below, there have been no material changes from the risk factors previously disclosed in Part I, Item 1A, "Risk Factors," in our 2025 Annual Report. The risk factors below supplement, and should be read together with, the risk factors in our 2025 Annual Report. +11 more paragraphs

Data on this page was fetched . The filing on SEC.gov is the record.